Skip to main content
Scheme 1 | Journal of Nanobiotechnology

Scheme 1

From: Artificial stem cells mediated inflammation-tropic delivery of antiviral drugs for pneumonia treatment

Scheme 1

Scheme illustration of biomimetic nanoparticles for the therapy of pneumonia. A The preparation of MPDGP; B The treatment with MPDGP for CMV induced pneumonia. mBMSCs mouse bone marrow mesenchymal stem cells, PLGA poly(lactic-co-glycolic acid), DOTAP 1,2-dioleoyl-3-trimethylammonium-propane, GCV ganciclovir, PFA phosphonoformate, PDGP PLGA/DOTAP/GCV/PFA, MPDGP MSCM/PLGA/DOTAP/GCV/PFA, CMV Cytomegalovirus

Back to article page